Intravenous Catheters Market Outlook: Growth in Surgical Procedures to Drive Market Growth to US$ 28.91 Billion by 2033

As per the latest market research by Business Market Insights (BMI), the research report "Intravenous Catheters Market Outlook Size and Forecast (2022–2033)" forecasts how the market is set to surge 122.2% by 2033 as rise in surgical procedures reshapes the intravenous catheters ecosystem. The report highlights technological advancements in PICCs catheters, revolutionizing the global landscape of intravenous catheters.

The report forecasts the market to expand from US$ 13.01 billion in 2024 to US$ 28.91 billion by 2033, registering a robust CAGR of 9.28% over the 2025–2033 period.

Technological​‍​‌‍​‍‌​‍​‌‍​‍‌ advancements in peripherally inserted central catheters (PICCs) are a major factor in changing the worldwide intravenous catheters market in a very positive way by making them safer, more efficient, and bringing better patient outcomes to different care settings. One of the innovations has been made in the catheter material where now softer, biocompatible polyurethane or silicone are used, these materials have increased the flexibility and the lifespan of the catheter while the risk of vessel irritation and thrombosis has been lowered. The use of antimicrobial and anti-thrombogenic agents has essentially enabled the eradication of catheter-related bloodstream infections and closures thus providing solution to these complications, which have been issues associated with long-term intravenous access. The production of power-injectable PICCs has heightened the scope of their application as a means for high-pressure contrast media delivery in diagnostic imaging, thus leading to workflow efficiency. Also, the continued efforts to design longer-dwell and low-maintenance PICCs have resulted in fewer catheter changes thus a saving in healthcare costs and better patient satisfaction. The development of smart PICCs with built-in sensors and better hub designs is the next step which will lead to more efficient monitoring, safe connections, and less risk of contamination. Together, these developments in technology are making PICCs the most suitable and efficient vascular access devices, thus they are widely being accepted and the global intravenous catheters market is being transformed in safety, clinical outcomes and operational ​‍​‌‍​‍‌​‍​‌‍​‍‌efficiency. ​‍​‌‍​‍‌​

Overview of report findings

Market Growth

The Intravenous Catheters Market is projected to grow from US$ 13.01 billion in 2024 to US$ 28.91 billion by 2033, registering a compound annual growth rate (CAGR) of 9.28% between 2025 and 2033.

The growth in the number of surgical procedures and growing preference for peripherally inserted central catheter are key factors propelling market growth. Advancements in PICCs catheters are transforming the landscape of intravenous catheters.

Growing Preference for Peripherally Inserted Central Catheter

The growing preference for peripherally inserted central catheters (PICCs) is a significant factor driving the intravenous catheters market, as these devices offer a safe, reliable, and cost-effective solution for medium- to long-term intravenous therapy. PICCs are increasingly favoured over traditional central venous catheters due to their lower risk of complications such as pneumothorax and reduced need for surgical insertion, making them suitable for a wide range of clinical settings including oncology, critical care, and home healthcare. The rising incidence of cancer and chronic diseases that require prolonged administration of chemotherapy, antibiotics, parenteral nutrition, and other intravenous medications has further accelerated PICC adoption. Additionally, advancements in PICC technology, such as antimicrobial coatings, improved catheter materials, and ultrasound-guided insertion techniques, have enhanced safety, patient comfort, and placement accuracy. Healthcare providers are also increasingly adopting PICCs due to their longer dwell time, reduced need for repeated venepuncture, and lower overall treatment costs. As healthcare systems continue to emphasize patient safety, infection prevention, and efficient long-term vascular access, the growing preference for PICCs is playing a crucial role in driving sustained growth in the intravenous catheters market.

Increasing Surgical Procedures

The increasing number of surgical procedures worldwide is a major driver of growth in the intravenous catheters market, as IV catheters are essential for administering anesthesia, fluids, blood products, and medications before, during, and after surgery. Rising prevalence of chronic diseases such as cardiovascular disorders, cancer, orthopaedic conditions, and gastrointestinal diseases has significantly increased the volume of both elective and emergency surgeries, thereby boosting demand for reliable and safe vascular access devices. In addition, the growing aging population, which is more susceptible to conditions requiring surgical intervention, further contributes to the rising use of intravenous catheters across hospitals and surgical centers. Advancements in surgical techniques, including minimally invasive and robotic-assisted procedures, have also expanded surgical volumes, necessitating efficient intravenous access for perioperative care. Moreover, the expansion of ambulatory surgical centers and day-care surgeries has increased the need for easy-to-insert, short- and medium-term IV catheters that support faster patient turnover and improved clinical efficiency. As healthcare systems continue to prioritize surgical care delivery and patient safety, the sustained rise in surgical procedures directly reinforces the demand for advanced intravenous catheter solutions, driving steady market growth globally.

Geographic Insights

North America holds the largest share of the intravenous catheters market due to its well-established healthcare infrastructure, high hospitalization and surgical procedure rates, and widespread adoption of advanced vascular access technologies, particularly in oncology, critical care, and chronic disease management. The region also benefits from strong presence of leading medical device manufacturers, favourable reimbursement policies, and high awareness of infection prevention, driving demand for antimicrobial and needle-less catheter systems. Europe represents the second-largest market, supported by a robust public healthcare system, increasing aging population, and rising prevalence of chronic conditions requiring long-term intravenous therapy. Stringent regulatory standards and strong emphasis on patient safety and infection control further contribute to steady adoption of technologically advanced intravenous catheters across European countries. Meanwhile, Asia Pacific is the fastest-growing region in the intravenous catheters market, driven by rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and growing patient populations in countries such as China and India. Rising awareness of modern IV access solutions, improving access to hospital and ambulatory care services, and a surge in medical tourism and surgical volumes are further accelerating market growth in the region, making Asia Pacific a key focus area for future market expansion.

Market Segmentation

• Based on Product, the market is segmented into peripheral catheter, central catheter, PICC catheter, and others. The peripheral catheter segment dominated the market in 2024.
• Based on Coating Type, the market is segmented into coated catheters, uncoated catheters. The coated catheters segment dominated the market in 2024.
• Based on Lumen, the market is segmented into single-lumen, multi-lumen. The multi-lumen segment dominated the market in 2024.

• Based on End User, the market is segmented into hospitals & clinics, ambulatory surgical centers, diagnostic imaging centers, and others. The hospitals & clinics dominated the market in 2024.

Competitive Strategy & Development

Key Players: The Intravenous Catheters Market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Mediplus India Ltd
2. Boston Scientific Corp
3. Becton, Dickinson and Co
4. Teleflex Inc
5. B Braun SE
6. Sterimed Medical Devices Pvt Ltd
7. Terumo Corp

Trending Topics: Antimicrobial and coated intravenous catheters, Needle-less IV catheter systems, Catheter-related bloodstream infection (CRBSI) prevention, Peripherally inserted central catheters (PICC) innovation, Long-dwell and extended-use IV catheters, Ultrasound-guided IV catheter placement, Smart and sensor-enabled IV catheters, Shift toward outpatient and ambulatory IV therapy, Infection control and patient safety protocols, Minimally invasive vascular access technologies

Global Headlines

• " FDA Clears BD’s New Peripheral IV Catheter Designed to Reduce Complications - In October 2025, Becton Dickinson (BD) received FDA clearance for its latest peripheral intravenous catheter, which incorporates advanced blood‑control technology. This innovation is designed to minimize accidental blood exposure during insertion, reduce the risk of infiltration, and improve patient comfort. The catheter also features ergonomic enhancements for clinicians, making insertion smoother and reducing multiple attempts. Strategically, this clearance strengthens BD’s leadership in vascular access, particularly in the U.S. where peripheral IVs are the most commonly used devices in hospitals. The launch aligns with growing demand for safer, more efficient IV therapy solutions in emergency departments and outpatient infusion centers."
• " NHS England Expands Use of Multi‑Lumen IV Catheters for Oncology Patients - In July 2025, NHS England announced a nationwide expansion of multi‑lumen intravenous catheters in oncology wards. These catheters allow simultaneous administration of chemotherapy, hydration, and supportive medications through separate lumens, reducing the need for multiple line insertions. The initiative is part of NHS England’s strategy to improve patient comfort, reduce infection risk, and streamline oncology workflows. Multi‑lumen catheters are particularly beneficial for patients undergoing complex regimens, as they minimize line changes and improve therapy efficiency. Strategically, this expansion underscores the NHS’s commitment to modernizing oncology care and adopting devices that enhance both patient safety and clinician productivity."

Conclusion

The intravenous catheters market is expected to witness sustained growth over the coming years, supported by increasing hospitalization rates, a rising number of surgical procedures, and the growing burden of chronic diseases such as cancer, cardiovascular disorders, and diabetes that require long-term intravenous therapy. High adoption of peripherally inserted central catheters (PICCs), particularly in oncology and critical care, continues to drive market expansion, while heightened awareness of infection prevention has further increased demand for coated and antimicrobial catheters. Technological advancements remain a key growth catalyst, with a notable shift from traditional closed IV catheter systems toward needle-less designs aimed at reducing needlestick injuries and catheter-related bloodstream infections (CRBSIs). Despite these positive trends, the market faces challenges from the risk of catheter-associated infections and complications, which can impact patient outcomes and increase healthcare costs, thereby necessitating continuous innovation and adherence to strict clinical protocols. Nevertheless, significant opportunities lie in the development of longer-dwell, low-maintenance catheter solutions that improve patient comfort and reduce the need for frequent replacements. Additionally, the growing shift toward outpatient and ambulatory care settings is reshaping demand patterns, as healthcare providers seek cost-effective, safe, and easy-to-manage intravenous access solutions. Collectively, these factors position the intravenous catheters market for steady growth, driven by innovation, evolving care delivery models, and an increasing emphasis on patient safety and efficiency across healthcare systems worldwide.